MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, WGSWW made $427,539K in revenue. -$20,915K in net income. Net profit margin of -4.89%.

Income Overview

Revenue
$427,539K
Net Income
-$20,915K
Net Profit Margin
-4.89%
EPS
-$0.73
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diagnostic Test
    • Product And Service Other
Revenue Breakdown
    • Gene Dx
    • All Other Segments

Income Statement
2025-12-31
Total revenue
427,539
Cost of services
129,366
Gross profit
298,173
Research and development
72,026
Selling and marketing
88,405
General and administrative
150,819
Impairment loss
0
Other operating expenses, net
0
Loss from operations
-13,077
Change in fair value of financial liabilities
-1,204
Interest (expense) income, net
-2,539
Other (expense) income, net
-4,317
Total non-operating (expense) income, net
-8,060
Loss before income taxes
-21,137
Income tax benefit
-116
Net loss
-21,021
Unrealized gain related to available for sale securities, net
106
Comprehensive loss
-20,915
Basic EPS
-0.73
Diluted EPS
-0.73
Basic Average Shares
28,641,734
Diluted Average Shares
28,641,734
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$20,915K Unrealized gain related toavailable for sale...$106K Gene Dx$415,641K All Other Segments$1,027K Gene Dx$7,447K All Other Segments$3,424K Net loss-$21,021K Income tax benefit-$116K Diagnostic Test$416,668K Product And ServiceOther$10,871K Loss before incometaxes-$21,137K Total revenue$427,539K Loss from operations-$13,077K Total non-operating(expense) income, net-$8,060K Gross profit$298,173K Cost of services$129,366K General andadministrative$150,819K Other (expense)income, net-$4,317K Interest (expense)income, net-$2,539K Change in fair value offinancial liabilities-$1,204K Selling and marketing$88,405K Research and development$72,026K

GeneDx Holdings Corp. (WGSWW)

GeneDx Holdings Corp. (WGSWW)